Financing ·
OS Therapies Incorporated entered into an Open Market Sale Agreement with Jefferies LLC on August 21, 2026…
OSTXOS Therapies Inc
OS Therapies Incorporated entered into an Open Market Sale Agreement with Jefferies LLC on August 21, 2026, establishing an at-the-market (ATM) equity offering program. Under this agreement, the company may offer and sell shares of its common stock from time to time up to an aggregate offering price of $75 million. The sales agent receives a commission equal to 3.0% of the gross proceeds, and the company agreed to reimburse legal fees not exceeding $100,000. Net proceeds are intended to fund clinical development activities, advance research programs, and potentially acquire complementary technologies or businesses. OS Therapies operates in the biotechnology industry, focusing on drug discovery and development.